Comparison of mutations in human parainfluenza viruses during passage in primary human bronchial/tracheal epithelial air-liquid interface cultures and cell lines
Adaptation of viruses to cultured cells can increase the risk of misinterpretation in virological characterization of clinical isolates. In human parainfluenza virus (HPIV) 3, it has been reported that the human airway epithelial and lung organoid models are preferable for the study of viral charact...
Saved in:
| Published in | Microbiology Spectrum Vol. 12; no. 9; p. e0116424 |
|---|---|
| Main Authors | , , , , , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
United States
American Society for Microbiology
03.09.2024
|
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | Adaptation of viruses to cultured cells can increase the risk of misinterpretation in virological characterization of clinical isolates. In human parainfluenza virus (HPIV) 3, it has been reported that the human airway epithelial and lung organoid models are preferable for the study of viral characteristics of clinical strains without mutations. Therefore, we analyzed clinical isolates of all four HPIVs for the occurrence of mutations after five laboratory passages in human bronchial/tracheal epithelial cell air-liquid interface (HBTEC-ALI) or conventional culture. We found a high risk of hemagglutinin-neuraminidase mutagenesis in all four HPIVs in conventional cultured cells. In addition, in HPIV1 and HPIV2, mutations of the large protein were also more frequent in conventional cultured cells than in HBTEC-ALI culture. HBTEC-ALI culture was useful for maintaining the original sequence and characteristics of clinical isolates in all four HPIVs. The present study contributes to the understanding of HPIV pathogenesis and antiviral strategies. |
|---|---|
| AbstractList | Human parainfluenza virus (HPIV) causes respiratory infections, which are exacerbated in children and older people. Correct evaluation of viral characteristics is essential for the study of countermeasures. However, adaptation of viruses to cultured cells during isolation or propagation might select laboratory passage-associated mutations that modify the characteristics of the virus. It was previously reported that adaptation of HPIV3, but not other HPIVs, was avoided in human airway epithelia. To examine the influence of laboratory passage on the genomes of HPIV1-HPIV4, we evaluated the occurrence of mutations after passage in primary human bronchial/tracheal epithelial cell air-liquid interface (HBTEC-ALI) culture and conventional cultured cells (Vero cells expressing the transmembrane protease, serine 2, and normal Vero cells). The occurrence of mutations was significantly lower in HBTEC-ALI than in conventional culture. In HBTEC-ALI culture, most of the mutations were silent or remained at low variant frequency, resulting in less impact on the viral consensus sequence. In contrast, passage in conventional culture induced or selected genetic mutations at high frequency with passage-associated unique substitutions. High mutagenesis of hemagglutinin-neuraminidase was commonly observed in all four HPIVs, and mutations even occurred in a single passage. In addition, in HPIV1 and HPIV2, mutations in the large protein were more frequent. These results indicate that passage in HBTEC-ALI culture is more suitable than conventional culture for maintaining the original characteristics of clinical isolates in all four HPIVs, which can help with the understanding of viral pathogenesis.
Adaptation of viruses to cultured cells can increase the risk of misinterpretation in virological characterization of clinical isolates. In human parainfluenza virus (HPIV) 3, it has been reported that the human airway epithelial and lung organoid models are preferable for the study of viral characteristics of clinical strains without mutations. Therefore, we analyzed clinical isolates of all four HPIVs for the occurrence of mutations after five laboratory passages in human bronchial/tracheal epithelial cell air-liquid interface (HBTEC-ALI) or conventional culture. We found a high risk of hemagglutinin-neuraminidase mutagenesis in all four HPIVs in conventional cultured cells. In addition, in HPIV1 and HPIV2, mutations of the large protein were also more frequent in conventional cultured cells than in HBTEC-ALI culture. HBTEC-ALI culture was useful for maintaining the original sequence and characteristics of clinical isolates in all four HPIVs. The present study contributes to the understanding of HPIV pathogenesis and antiviral strategies. Adaptation of viruses to cultured cells can increase the risk of misinterpretation in virological characterization of clinical isolates. In human parainfluenza virus (HPIV) 3, it has been reported that the human airway epithelial and lung organoid models are preferable for the study of viral characteristics of clinical strains without mutations. Therefore, we analyzed clinical isolates of all four HPIVs for the occurrence of mutations after five laboratory passages in human bronchial/tracheal epithelial cell air-liquid interface (HBTEC-ALI) or conventional culture. We found a high risk of hemagglutinin-neuraminidase mutagenesis in all four HPIVs in conventional cultured cells. In addition, in HPIV1 and HPIV2, mutations of the large protein were also more frequent in conventional cultured cells than in HBTEC-ALI culture. HBTEC-ALI culture was useful for maintaining the original sequence and characteristics of clinical isolates in all four HPIVs. The present study contributes to the understanding of HPIV pathogenesis and antiviral strategies. Human parainfluenza virus (HPIV) causes respiratory infections, which are exacerbated in children and older people. Correct evaluation of viral characteristics is essential for the study of countermeasures. However, adaptation of viruses to cultured cells during isolation or propagation might select laboratory passage-associated mutations that modify the characteristics of the virus. It was previously reported that adaptation of HPIV3, but not other HPIVs, was avoided in human airway epithelia. To examine the influence of laboratory passage on the genomes of HPIV1–HPIV4, we evaluated the occurrence of mutations after passage in primary human bronchial/tracheal epithelial cell air-liquid interface (HBTEC-ALI) culture and conventional cultured cells (Vero cells expressing the transmembrane protease, serine 2, and normal Vero cells). The occurrence of mutations was significantly lower in HBTEC-ALI than in conventional culture. In HBTEC-ALI culture, most of the mutations were silent or remained at low variant frequency, resulting in less impact on the viral consensus sequence. In contrast, passage in conventional culture induced or selected genetic mutations at high frequency with passage-associated unique substitutions. High mutagenesis of hemagglutinin-neuraminidase was commonly observed in all four HPIVs, and mutations even occurred in a single passage. In addition, in HPIV1 and HPIV2, mutations in the large protein were more frequent. These results indicate that passage in HBTEC-ALI culture is more suitable than conventional culture for maintaining the original characteristics of clinical isolates in all four HPIVs, which can help with the understanding of viral pathogenesis. Human parainfluenza virus (HPIV) causes respiratory infections, which are exacerbated in children and older people. Correct evaluation of viral characteristics is essential for the study of countermeasures. However, adaptation of viruses to cultured cells during isolation or propagation might select laboratory passage-associated mutations that modify the characteristics of the virus. It was previously reported that adaptation of HPIV3, but not other HPIVs, was avoided in human airway epithelia. To examine the influence of laboratory passage on the genomes of HPIV1–HPIV4, we evaluated the occurrence of mutations after passage in primary human bronchial/tracheal epithelial cell air-liquid interface (HBTEC-ALI) culture and conventional cultured cells (Vero cells expressing the transmembrane protease, serine 2, and normal Vero cells). The occurrence of mutations was significantly lower in HBTEC-ALI than in conventional culture. In HBTEC-ALI culture, most of the mutations were silent or remained at low variant frequency, resulting in less impact on the viral consensus sequence. In contrast, passage in conventional culture induced or selected genetic mutations at high frequency with passage-associated unique substitutions. High mutagenesis of hemagglutinin-neuraminidase was commonly observed in all four HPIVs, and mutations even occurred in a single passage. In addition, in HPIV1 and HPIV2, mutations in the large protein were more frequent. These results indicate that passage in HBTEC-ALI culture is more suitable than conventional culture for maintaining the original characteristics of clinical isolates in all four HPIVs, which can help with the understanding of viral pathogenesis.IMPORTANCEAdaptation of viruses to cultured cells can increase the risk of misinterpretation in virological characterization of clinical isolates. In human parainfluenza virus (HPIV) 3, it has been reported that the human airway epithelial and lung organoid models are preferable for the study of viral characteristics of clinical strains without mutations. Therefore, we analyzed clinical isolates of all four HPIVs for the occurrence of mutations after five laboratory passages in human bronchial/tracheal epithelial cell air-liquid interface (HBTEC-ALI) or conventional culture. We found a high risk of hemagglutinin-neuraminidase mutagenesis in all four HPIVs in conventional cultured cells. In addition, in HPIV1 and HPIV2, mutations of the large protein were also more frequent in conventional cultured cells than in HBTEC-ALI culture. HBTEC-ALI culture was useful for maintaining the original sequence and characteristics of clinical isolates in all four HPIVs. The present study contributes to the understanding of HPIV pathogenesis and antiviral strategies. ABSTRACT Human parainfluenza virus (HPIV) causes respiratory infections, which are exacerbated in children and older people. Correct evaluation of viral characteristics is essential for the study of countermeasures. However, adaptation of viruses to cultured cells during isolation or propagation might select laboratory passage-associated mutations that modify the characteristics of the virus. It was previously reported that adaptation of HPIV3, but not other HPIVs, was avoided in human airway epithelia. To examine the influence of laboratory passage on the genomes of HPIV1–HPIV4, we evaluated the occurrence of mutations after passage in primary human bronchial/tracheal epithelial cell air-liquid interface (HBTEC-ALI) culture and conventional cultured cells (Vero cells expressing the transmembrane protease, serine 2, and normal Vero cells). The occurrence of mutations was significantly lower in HBTEC-ALI than in conventional culture. In HBTEC-ALI culture, most of the mutations were silent or remained at low variant frequency, resulting in less impact on the viral consensus sequence. In contrast, passage in conventional culture induced or selected genetic mutations at high frequency with passage-associated unique substitutions. High mutagenesis of hemagglutinin-neuraminidase was commonly observed in all four HPIVs, and mutations even occurred in a single passage. In addition, in HPIV1 and HPIV2, mutations in the large protein were more frequent. These results indicate that passage in HBTEC-ALI culture is more suitable than conventional culture for maintaining the original characteristics of clinical isolates in all four HPIVs, which can help with the understanding of viral pathogenesis.IMPORTANCEAdaptation of viruses to cultured cells can increase the risk of misinterpretation in virological characterization of clinical isolates. In human parainfluenza virus (HPIV) 3, it has been reported that the human airway epithelial and lung organoid models are preferable for the study of viral characteristics of clinical strains without mutations. Therefore, we analyzed clinical isolates of all four HPIVs for the occurrence of mutations after five laboratory passages in human bronchial/tracheal epithelial cell air-liquid interface (HBTEC-ALI) or conventional culture. We found a high risk of hemagglutinin-neuraminidase mutagenesis in all four HPIVs in conventional cultured cells. In addition, in HPIV1 and HPIV2, mutations of the large protein were also more frequent in conventional cultured cells than in HBTEC-ALI culture. HBTEC-ALI culture was useful for maintaining the original sequence and characteristics of clinical isolates in all four HPIVs. The present study contributes to the understanding of HPIV pathogenesis and antiviral strategies. Human parainfluenza virus (HPIV) causes respiratory infections, which are exacerbated in children and older people. Correct evaluation of viral characteristics is essential for the study of countermeasures. However, adaptation of viruses to cultured cells during isolation or propagation might select laboratory passage-associated mutations that modify the characteristics of the virus. It was previously reported that adaptation of HPIV3, but not other HPIVs, was avoided in human airway epithelia. To examine the influence of laboratory passage on the genomes of HPIV1-HPIV4, we evaluated the occurrence of mutations after passage in primary human bronchial/tracheal epithelial cell air-liquid interface (HBTEC-ALI) culture and conventional cultured cells (Vero cells expressing the transmembrane protease, serine 2, and normal Vero cells). The occurrence of mutations was significantly lower in HBTEC-ALI than in conventional culture. In HBTEC-ALI culture, most of the mutations were silent or remained at low variant frequency, resulting in less impact on the viral consensus sequence. In contrast, passage in conventional culture induced or selected genetic mutations at high frequency with passage-associated unique substitutions. High mutagenesis of hemagglutinin-neuraminidase was commonly observed in all four HPIVs, and mutations even occurred in a single passage. In addition, in HPIV1 and HPIV2, mutations in the large protein were more frequent. These results indicate that passage in HBTEC-ALI culture is more suitable than conventional culture for maintaining the original characteristics of clinical isolates in all four HPIVs, which can help with the understanding of viral pathogenesis.Human parainfluenza virus (HPIV) causes respiratory infections, which are exacerbated in children and older people. Correct evaluation of viral characteristics is essential for the study of countermeasures. However, adaptation of viruses to cultured cells during isolation or propagation might select laboratory passage-associated mutations that modify the characteristics of the virus. It was previously reported that adaptation of HPIV3, but not other HPIVs, was avoided in human airway epithelia. To examine the influence of laboratory passage on the genomes of HPIV1-HPIV4, we evaluated the occurrence of mutations after passage in primary human bronchial/tracheal epithelial cell air-liquid interface (HBTEC-ALI) culture and conventional cultured cells (Vero cells expressing the transmembrane protease, serine 2, and normal Vero cells). The occurrence of mutations was significantly lower in HBTEC-ALI than in conventional culture. In HBTEC-ALI culture, most of the mutations were silent or remained at low variant frequency, resulting in less impact on the viral consensus sequence. In contrast, passage in conventional culture induced or selected genetic mutations at high frequency with passage-associated unique substitutions. High mutagenesis of hemagglutinin-neuraminidase was commonly observed in all four HPIVs, and mutations even occurred in a single passage. In addition, in HPIV1 and HPIV2, mutations in the large protein were more frequent. These results indicate that passage in HBTEC-ALI culture is more suitable than conventional culture for maintaining the original characteristics of clinical isolates in all four HPIVs, which can help with the understanding of viral pathogenesis.Adaptation of viruses to cultured cells can increase the risk of misinterpretation in virological characterization of clinical isolates. In human parainfluenza virus (HPIV) 3, it has been reported that the human airway epithelial and lung organoid models are preferable for the study of viral characteristics of clinical strains without mutations. Therefore, we analyzed clinical isolates of all four HPIVs for the occurrence of mutations after five laboratory passages in human bronchial/tracheal epithelial cell air-liquid interface (HBTEC-ALI) or conventional culture. We found a high risk of hemagglutinin-neuraminidase mutagenesis in all four HPIVs in conventional cultured cells. In addition, in HPIV1 and HPIV2, mutations of the large protein were also more frequent in conventional cultured cells than in HBTEC-ALI culture. HBTEC-ALI culture was useful for maintaining the original sequence and characteristics of clinical isolates in all four HPIVs. The present study contributes to the understanding of HPIV pathogenesis and antiviral strategies.IMPORTANCEAdaptation of viruses to cultured cells can increase the risk of misinterpretation in virological characterization of clinical isolates. In human parainfluenza virus (HPIV) 3, it has been reported that the human airway epithelial and lung organoid models are preferable for the study of viral characteristics of clinical strains without mutations. Therefore, we analyzed clinical isolates of all four HPIVs for the occurrence of mutations after five laboratory passages in human bronchial/tracheal epithelial cell air-liquid interface (HBTEC-ALI) or conventional culture. We found a high risk of hemagglutinin-neuraminidase mutagenesis in all four HPIVs in conventional cultured cells. In addition, in HPIV1 and HPIV2, mutations of the large protein were also more frequent in conventional cultured cells than in HBTEC-ALI culture. HBTEC-ALI culture was useful for maintaining the original sequence and characteristics of clinical isolates in all four HPIVs. The present study contributes to the understanding of HPIV pathogenesis and antiviral strategies. |
| Author | Reiko Suwa Ken-Ichi Hanaki Satoko Sugimoto Hisao Okabe Sakurako Norito Kazuya Shirato Takashi Ono Miyuki Kawase Mina Chishiki Yohei Kume Mitsuaki Hosoya Koichi Hashimoto |
| Author_xml | – sequence: 1 givenname: Satoko orcidid: 0009-0002-5042-1543 surname: Sugimoto fullname: Sugimoto, Satoko organization: Department of Virology III, National Institute of Infectious Diseases, Tokyo, Japan, Research Center for Biosafety, Laboratory Animal, and Pathogen Bank, National Institute of Infectious Diseases, Tokyo, Japan – sequence: 2 givenname: Miyuki surname: Kawase fullname: Kawase, Miyuki organization: Department of Virology III, National Institute of Infectious Diseases, Tokyo, Japan – sequence: 3 givenname: Reiko surname: Suwa fullname: Suwa, Reiko organization: Department of Virology III, National Institute of Infectious Diseases, Tokyo, Japan – sequence: 4 givenname: Yohei surname: Kume fullname: Kume, Yohei organization: Department of Pediatrics, School of Medicine, Fukushima Medical University, Fukushima, Japan – sequence: 5 givenname: Mina surname: Chishiki fullname: Chishiki, Mina organization: Department of Pediatrics, School of Medicine, Fukushima Medical University, Fukushima, Japan – sequence: 6 givenname: Takashi surname: Ono fullname: Ono, Takashi organization: Department of Pediatrics, School of Medicine, Fukushima Medical University, Fukushima, Japan – sequence: 7 givenname: Hisao surname: Okabe fullname: Okabe, Hisao organization: Department of Pediatrics, School of Medicine, Fukushima Medical University, Fukushima, Japan – sequence: 8 givenname: Sakurako surname: Norito fullname: Norito, Sakurako organization: Department of Pediatrics, School of Medicine, Fukushima Medical University, Fukushima, Japan – sequence: 9 givenname: Ken-Ichi surname: Hanaki fullname: Hanaki, Ken-Ichi organization: Research Center for Biosafety, Laboratory Animal, and Pathogen Bank, National Institute of Infectious Diseases, Tokyo, Japan – sequence: 10 givenname: Mitsuaki surname: Hosoya fullname: Hosoya, Mitsuaki organization: Department of Pediatrics, School of Medicine, Fukushima Medical University, Fukushima, Japan – sequence: 11 givenname: Koichi orcidid: 0000-0003-4955-6221 surname: Hashimoto fullname: Hashimoto, Koichi organization: Department of Pediatrics, School of Medicine, Fukushima Medical University, Fukushima, Japan – sequence: 12 givenname: Kazuya orcidid: 0000-0002-3375-9799 surname: Shirato fullname: Shirato, Kazuya organization: Department of Virology III, National Institute of Infectious Diseases, Tokyo, Japan |
| BackLink | https://cir.nii.ac.jp/crid/1873680966341080704$$DView record in CiNii https://www.ncbi.nlm.nih.gov/pubmed/39078148$$D View this record in MEDLINE/PubMed |
| BookMark | eNp9kstuFDEQRVsoiISQD2CDesGCzSTlR7vbK4QiHpEisYG1Ve22Zxy57YndjgR_w5_iyUyihAUb26q696hcuq-boxCDaZq3BM4JocNF3hq9pDKfAyGCryh_0ZxQIroVcNkfPXkfN2c53wBUHXS0o6-aYyahHwgfTpo_l3HeYnI5hjbadi4LLi6G3LrQbsqMoa1ddMH6YsJvbO9cKtnkdirJhXVt5oxrs1Nvk5sx_Tq4xhSD3jj0F0tCvTHoW7N1y8b4WmvRpZV3t8VN1bmYZFGbVhe_lFTZGKZWG-9b74LJb5qXFn02Z4f7tPn55fOPy2-r6-9fry4_Xa9QACyrkaEEK6eejEJKlAMdjez4SJjgUgtASzvg_cCI0VSD5JxaYezIrbWdIIydNld77hTxRh1-oyI6dV-Iaa0wLU57owbBxCgHKSUnXKAdGEwTguhGBpT2vLI-7lnbMs5m0ibULfhn0Oed4DZqHe8UIawHykUlfDgQUrwtJi9qdnm3FAwmlqwYDAKEkByq9HwvxTxTdRNLCnVPioDa5UQ95ETd50TR3XTvnk73ONZDKqqA7AU6xZyTsY-S_0H7fzza7bNUP-j8f53v987gXDXtTjL0TAwghWCcwAA9cPYXJdnubA |
| CitedBy_id | crossref_primary_10_32604_or_2024_053635 crossref_primary_10_1016_j_virol_2024_110366 |
| Cites_doi | 10.7554/eLife.66815 10.1128/JVI.79.4.2383-2392.2005 10.1128/JCM.00848-07 10.1371/journal.pone.0079252 10.1016/j.virusres.2020.197963 10.1016/j.jcv.2018.02.009 10.1099/jgv.0.001453 10.1128/mBio.00898-18 10.1111/1348-0421.12446 10.1128/JVI.00602-16 10.1099/0022-1317-73-4-875 10.1128/spectrum.01920-23 10.1038/s41598-022-22060-z 10.1099/jmm.0.068189-0 10.1128/JVI.05873-11 10.1186/s12859-019-2606-y 10.1128/JVI.01965-14 10.1093/bib/bbx108 10.1128/mBio.01415-21 10.1128/mBio.00137-12 10.1002/jmv.24780 10.1128/mra.00411-22 10.1172/JCI150506 10.1371/journal.pone.0046048 10.1128/JVI.01965-12 10.1128/JCM.00398-08 10.1038/s41392-020-0184-0 10.1016/j.virol.2017.11.012 10.7883/yoken.JJID.2008.196 10.1128/mBio.00235-16 10.1371/journal.ppat.1003534 10.1016/j.virol.2006.12.026 10.3390/pathogens11070754 10.1128/mBio.00723-19 10.1128/JVI.01490-13 10.1128/JVI.00475-09 10.1128/JVI.00676-08 10.1128/mBio.00803-13 10.1073/pnas.1919837117 10.1126/sciadv.adf3731 10.3390/v4040613 10.7883/yoken.67.469 10.1093/molbev/msab120 10.1128/CMR.16.2.242-264.2003 10.1016/j.jviromet.2023.114812 10.1038/s41598-018-24767-4 10.1016/0042-6822(89)90508-4 10.1093/nar/gky427 |
| ContentType | Journal Article |
| Copyright | Copyright © 2024 Sugimoto et al. Copyright © 2024 Sugimoto et al. 2024 Sugimoto et al. |
| Copyright_xml | – notice: Copyright © 2024 Sugimoto et al. – notice: Copyright © 2024 Sugimoto et al. 2024 Sugimoto et al. |
| DBID | RYH AAYXX CITATION NPM 7X8 5PM DOA |
| DOI | 10.1128/spectrum.01164-24 |
| DatabaseName | CiNii Complete CrossRef PubMed MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
| DatabaseTitle | CrossRef PubMed MEDLINE - Academic |
| DatabaseTitleList | PubMed CrossRef MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Biology |
| EISSN | 2165-0497 |
| Editor | Kolawole, Abimbola O. |
| Editor_xml | – sequence: 1 givenname: Abimbola O. surname: Kolawole fullname: Kolawole, Abimbola O. |
| ExternalDocumentID | oai_doaj_org_article_8636b989994146af830dda065b302274 PMC11370246 spectrum01164-24 39078148 10_1128_spectrum_01164_24 |
| Genre | Journal Article |
| GrantInformation_xml | – fundername: MEXT | Japan Society for the Promotion of Science (JSPS) grantid: JP24K18456 – fundername: Japan Agency for Medical Research and Development (AMED) grantid: 23fk0108661j0001, 22fk0108543j0201, 24fk0108661j0002 – fundername: ; grantid: JP24K18456 – fundername: ; grantid: 23fk0108661j0001, 22fk0108543j0201, 24fk0108661j0002 |
| GroupedDBID | 53G AAGFI AAUOK ADBBV AGVNZ ALMA_UNASSIGNED_HOLDINGS EJD FF~ FRP GROUPED_DOAJ H13 M~E OK1 RPM RSF RYH AAYXX CITATION NPM UCJ 7X8 5PM |
| ID | FETCH-LOGICAL-a600t-b3a90f9d71b699a982be954b13649c60af25047831ec2c09442f6efb4fff56133 |
| IEDL.DBID | DOA |
| ISSN | 2165-0497 |
| IngestDate | Wed Aug 27 01:29:40 EDT 2025 Thu Aug 21 18:35:43 EDT 2025 Fri Jul 11 01:30:09 EDT 2025 Tue Sep 03 18:24:42 EDT 2024 Mon Jul 21 06:00:58 EDT 2025 Tue Jul 01 00:42:59 EDT 2025 Thu Apr 24 22:59:18 EDT 2025 Fri Jun 27 00:22:08 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 9 |
| Keywords | air-liquid interface culture cell culture adaptation hemagglutinin neuraminidase protein human parainfluenza virus quasispecies |
| Language | English |
| License | This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license. https://creativecommons.org/licenses/by/4.0 This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-a600t-b3a90f9d71b699a982be954b13649c60af25047831ec2c09442f6efb4fff56133 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 The authors declare no conflict of interest. |
| ORCID | 0009-0002-5042-1543 0000-0002-3375-9799 0000-0003-4955-6221 |
| OpenAccessLink | https://doaj.org/article/8636b989994146af830dda065b302274 |
| PMID | 39078148 |
| PQID | 3086066940 |
| PQPubID | 23479 |
| PageCount | 15 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_8636b989994146af830dda065b302274 pubmedcentral_primary_oai_pubmedcentral_nih_gov_11370246 proquest_miscellaneous_3086066940 asm2_journals_10_1128_spectrum_01164_24 pubmed_primary_39078148 crossref_primary_10_1128_spectrum_01164_24 crossref_citationtrail_10_1128_spectrum_01164_24 nii_cinii_1873680966341080704 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2024-09-03 |
| PublicationDateYYYYMMDD | 2024-09-03 |
| PublicationDate_xml | – month: 09 year: 2024 text: 2024-09-03 day: 03 |
| PublicationDecade | 2020 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States – name: 1752 N St., N.W., Washington, DC |
| PublicationTitle | Microbiology Spectrum |
| PublicationTitleAbbrev | Spectrum |
| PublicationTitleAlternate | Microbiol Spectr |
| PublicationYear | 2024 |
| Publisher | American Society for Microbiology |
| Publisher_xml | – name: American Society for Microbiology |
| References | e_1_3_5_28_2 e_1_3_5_27_2 e_1_3_5_26_2 e_1_3_5_25_2 e_1_3_5_24_2 e_1_3_5_23_2 e_1_3_5_22_2 e_1_3_5_21_2 e_1_3_5_43_2 e_1_3_5_44_2 e_1_3_5_45_2 e_1_3_5_46_2 e_1_3_5_47_2 e_1_3_5_48_2 e_1_3_5_49_2 e_1_3_5_29_2 e_1_3_5_2_2 e_1_3_5_40_2 e_1_3_5_41_2 e_1_3_5_42_2 e_1_3_5_8_2 e_1_3_5_20_2 e_1_3_5_7_2 e_1_3_5_9_2 e_1_3_5_4_2 e_1_3_5_3_2 e_1_3_5_6_2 e_1_3_5_5_2 e_1_3_5_17_2 e_1_3_5_39_2 e_1_3_5_16_2 e_1_3_5_38_2 e_1_3_5_15_2 e_1_3_5_37_2 e_1_3_5_14_2 e_1_3_5_36_2 e_1_3_5_12_2 e_1_3_5_35_2 e_1_3_5_13_2 e_1_3_5_34_2 e_1_3_5_10_2 e_1_3_5_33_2 e_1_3_5_11_2 e_1_3_5_32_2 e_1_3_5_19_2 e_1_3_5_18_2 e_1_3_5_31_2 e_1_3_5_30_2 Chang, A, Dutch, RE (B17) 2012; 4 Greninger, AL, Rybkina, K, Lin, MJ, Drew-Bear, J, Marcink, TC, Shean, RC, Makhsous, N, Boeckh, M, Harder, O, Bovier, F, Burstein, SR, Niewiesk, S, Rima, BK, Porotto, M, Moscona, A (B32) 2021; 131 Tsurudome, M, Nishio, M, Komada, H, Bando, H, Ito, Y (B26) 1989; 171 Dudouet, P, Colson, P, Aherfi, S, Levasseur, A, Beye, M, Delerce, J, Burel, E, Lavrard, P, Bader, W, Lagier, J-C, Fournier, P-E, La Scola, B, Raoult, D (B34) 2022; 12 Ogando, NS, Dalebout, TJ, Zevenhoven-Dobbe, JC, Limpens, R, van der Meer, Y, Caly, L, Druce, J, de Vries, JJC, Kikkert, M, Bárcena, M, Sidorov, I, Snijder, EJ (B13) 2020; 101 Porotto, M, Ferren, M, Chen, YW, Siu, Y, Makhsous, N, Rima, B, Briese, T, Greninger, AL, Snoeck, HW, Moscona, A (B10) 2019; 10 Porotto, M, Devito, I, Palmer, SG, Jurgens, EM, Yee, JL, Yokoyama, CC, Pessi, A, Moscona, A (B29) 2011; 85 Palermo, LM, Uppal, M, Skrabanek, L, Zumbo, P, Germer, S, Toussaint, NC, Rima, BK, Huey, D, Niewiesk, S, Porotto, M, Moscona, A (B7) 2016; 7 Palmer, SG, DeVito, I, Jenkins, SG, Niewiesk, S, Porotto, M, Moscona, A (B8) 2014; 88 Sugimoto, S, Kawase, M, Suwa, R, Kakizaki, M, Kume, Y, Chishiki, M, Ono, T, Okabe, H, Norito, S, Hosoya, M, Hashimoto, K, Shirato, K (B41) 2023; 322 Gorse, GJ, Patel, GB, Fan, X (B35) 2017; 89 Smielewska, A, Emmott, E, Goodfellow, I, Jalal, H (B4) 2018; 102 Katoh, K, Rozewicki, J, Yamada, KD (B47) 2019; 20 Linster, M, Do, LAH, Minh, NNQ, Chen, Y, Zhe, Z, Tuan, TA, Tuan, HM, Su, YCF, van Doorn, HR, Moorthy, M, Smith, GJD (B24) 2018; 8 Kawase, M, Suwa, R, Sugimoto, S, Kakizaki, M, Kume, Y, Chishiki, M, Ono, T, Okabe, H, Norito, S, Ujike, M, Hosoya, M, Hashimoto, K, Shirato, K (B11) 2024; 12 Connor, JH, McKenzie, MO, Parks, GD, Lyles, DS (B22) 2007; 362 Beck, ET, He, J, Nelson, MI, Bose, ME, Fan, J, Kumar, S, Henrickson, KJ (B23) 2012; 7 Shirogane, Y, Takeda, M, Iwasaki, M, Ishiguro, N, Takeuchi, H, Nakatsu, Y, Tahara, M, Kikuta, H, Yanagi, Y (B37) 2008; 82 Sasaki, M, Toba, S, Itakura, Y, Chambaro, HM, Kishimoto, M, Tabata, K, Intaruck, K, Uemura, K, Sanaki, T, Sato, A, Hall, WW, Orba, Y, Sawa, H (B15) 2021; 12 Shirogane, Y, Harada, H, Hirai, Y, Takemoto, R, Suzuki, T, Hashiguchi, T, Yanagi, Y (B33) 2023; 9 Shirato, K, Kawase, M, Matsuyama, S (B38) 2018; 517 Xu, R, Palmer, SG, Porotto, M, Palermo, LM, Niewiesk, S, Wilson, IA, Moscona, A (B9) 2013; 4 Porotto, M, Salah, ZW, Gui, L, DeVito, I, Jurgens, EM, Lu, H, Yokoyama, CC, Palermo, LM, Lee, KK, Moscona, A (B31) 2012; 86 Lu, IN, Muller, CP, He, FQ (B45) 2020; 283 Xia, S, Lan, Q, Su, S, Wang, X, Xu, W, Liu, Z, Zhu, Y, Wang, Q, Lu, L, Jiang, S (B20) 2020; 5 Tamura, K, Stecher, G, Kumar, S (B48) 2021; 38 Lee, HK, Tang, J-T, Kong, D-L, Loh, TP, Chiang, D-L, Lam, T-Y, Koay, E-C (B12) 2013; 8 Welch, BD, Yuan, P, Bose, S, Kors, CA, Lamb, RA, Jardetzky, TS (B28) 2013; 9 Palmer, SG, Porotto, M, Palermo, LM, Cunha, LF, Greengard, O, Moscona, A (B6) 2012; 3 van de Pol, AC, van Loon, AM, Wolfs, TFW, Jansen, NJG, Nijhuis, M, Breteler, EK, Schuurman, R, Rossen, JWA (B43) 2007; 45 Palermo, LM, Porotto, M, Yokoyama, CC, Palmer, SG, Mungall, BA, Greengard, O, Niewiesk, S, Moscona, A (B30) 2009; 83 Iketani, S, Shean, RC, Ferren, M, Makhsous, N, Aquino, DB, des Georges, A, Rima, B, Mathieu, C, Porotto, M, Moscona, A, Greninger, AL (B5) 2018; 9 Abdella, R, Aggarwal, M, Okura, T, Lamb, RA, He, Y (B19) 2020; 117 Shean, RC, Makhsous, N, Stoddard, GD, Lin, MJ, Greninger, AL (B44) 2019; 20 Kaida, A, Kubo, H, Takakura, K, Sekiguchi, J, Yamamoto, SP, Kohdera, U, Togawa, M, Amo, K, Shiomi, M, Ohyama, M, Goto, K, Hase, A, Kageyama, T, Iritani, N (B42) 2014; 67 Waterhouse, A, Bertoni, M, Bienert, S, Studer, G, Tauriello, G, Gumienny, R, Heer, FT, de Beer, TAP, Rempfer, C, Bordoli, L, Lepore, R, Schwede, T (B46) 2018; 46 Henrickson, KJ (B1) 2003; 16 Sato, K, Watanabe, O, Ohmiya, S, Chiba, F, Hayashi, M, Suzuki, T, Kawakami, K, Nishimura, H (B2) 2016; 60 Lamers, MM, Mykytyn, AZ, Breugem, TI, Wang, Y, Wu, DC, Riesebosch, S, van den Doel, PB, Schipper, D, Bestebroer, T, Wu, NC, Haagmans, BL (B14) 2021; 10 Oh, DY, Barr, IG, Mosse, JA, Laurie, KL (B16) 2008; 46 Mizuta, K, Abiko, C, Aoki, Y, Suto, A, Hoshina, H, Itagaki, T, Katsushima, N, Matsuzaki, Y, Hongo, S, Noda, M, Kimura, H, Ootani, K (B3) 2008; 61 Sugimoto, S, Kume, Y, Suwa, R, Kawase, M, Kakizaki, M, Egawa, K, Ono, T, Chishiki, M, Okabe, H, Norito, S, Sato, M, Sakuma, H, Suzuki, S, Hosoya, M, Takeda, M, Hashimoto, K, Shirato, K (B40) 2022; 11 Abe, M, Tahara, M, Sakai, K, Yamaguchi, H, Kanou, K, Shirato, K, Kawase, M, Noda, M, Kimura, H, Matsuyama, S, Fukuhara, H, Mizuta, K, Maenaka, K, Ami, Y, Esumi, M, Kato, A, Takeda, M (B18) 2013; 87 Porotto, M, Murrell, M, Greengard, O, Doctor, L, Moscona, A (B27) 2005; 79 Suwa, R, Kume, Y, Kawase, M, Chishiki, M, Ono, T, Norito, S, Sato, K, Okamoto, M, Kumaki, S, Nagai, Y, Hosoya, M, Takeda, M, Nishimura, H, Hashimoto, K, Shirato, K (B39) 2022; 11 Bloyet, L-M, Welsch, J, Enchery, F, Mathieu, C, de Breyne, S, Horvat, B, Grigorov, B, Gerlier, D (B21) 2016; 90 Komada, H, Kusagawa, S, Orvell, C, Tsurudome, M, Nishio, M, Bando, H, Kawano, M, Matsumura, H, Norrby, E, Ito, Y (B25) 1992; 73 Mizuta, K, Tsukagoshi, H, Ikeda, T, Aoki, Y, Abiko, C, Itagaki, T, Nagano, M, Noda, M, Kimura, H (B36) 2014; 63 |
| References_xml | – ident: e_1_3_5_15_2 doi: 10.7554/eLife.66815 – ident: e_1_3_5_28_2 doi: 10.1128/JVI.79.4.2383-2392.2005 – ident: e_1_3_5_44_2 doi: 10.1128/JCM.00848-07 – ident: e_1_3_5_13_2 doi: 10.1371/journal.pone.0079252 – ident: e_1_3_5_46_2 doi: 10.1016/j.virusres.2020.197963 – ident: e_1_3_5_5_2 doi: 10.1016/j.jcv.2018.02.009 – ident: e_1_3_5_14_2 doi: 10.1099/jgv.0.001453 – ident: e_1_3_5_6_2 doi: 10.1128/mBio.00898-18 – ident: e_1_3_5_3_2 doi: 10.1111/1348-0421.12446 – ident: e_1_3_5_22_2 doi: 10.1128/JVI.00602-16 – ident: e_1_3_5_26_2 doi: 10.1099/0022-1317-73-4-875 – ident: e_1_3_5_12_2 doi: 10.1128/spectrum.01920-23 – ident: e_1_3_5_35_2 doi: 10.1038/s41598-022-22060-z – ident: e_1_3_5_37_2 doi: 10.1099/jmm.0.068189-0 – ident: e_1_3_5_30_2 doi: 10.1128/JVI.05873-11 – ident: e_1_3_5_45_2 doi: 10.1186/s12859-019-2606-y – ident: e_1_3_5_9_2 doi: 10.1128/JVI.01965-14 – ident: e_1_3_5_48_2 doi: 10.1093/bib/bbx108 – ident: e_1_3_5_16_2 doi: 10.1128/mBio.01415-21 – ident: e_1_3_5_7_2 doi: 10.1128/mBio.00137-12 – ident: e_1_3_5_36_2 doi: 10.1002/jmv.24780 – ident: e_1_3_5_41_2 doi: 10.1128/mra.00411-22 – ident: e_1_3_5_33_2 doi: 10.1172/JCI150506 – ident: e_1_3_5_24_2 doi: 10.1371/journal.pone.0046048 – ident: e_1_3_5_32_2 doi: 10.1128/JVI.01965-12 – ident: e_1_3_5_17_2 doi: 10.1128/JCM.00398-08 – ident: e_1_3_5_21_2 doi: 10.1038/s41392-020-0184-0 – ident: e_1_3_5_39_2 doi: 10.1016/j.virol.2017.11.012 – ident: e_1_3_5_4_2 doi: 10.7883/yoken.JJID.2008.196 – ident: e_1_3_5_8_2 doi: 10.1128/mBio.00235-16 – ident: e_1_3_5_29_2 doi: 10.1371/journal.ppat.1003534 – ident: e_1_3_5_23_2 doi: 10.1016/j.virol.2006.12.026 – ident: e_1_3_5_40_2 doi: 10.3390/pathogens11070754 – ident: e_1_3_5_11_2 doi: 10.1128/mBio.00723-19 – ident: e_1_3_5_19_2 doi: 10.1128/JVI.01490-13 – ident: e_1_3_5_31_2 doi: 10.1128/JVI.00475-09 – ident: e_1_3_5_38_2 doi: 10.1128/JVI.00676-08 – ident: e_1_3_5_10_2 doi: 10.1128/mBio.00803-13 – ident: e_1_3_5_20_2 doi: 10.1073/pnas.1919837117 – ident: e_1_3_5_34_2 doi: 10.1126/sciadv.adf3731 – ident: e_1_3_5_18_2 doi: 10.3390/v4040613 – ident: e_1_3_5_43_2 doi: 10.7883/yoken.67.469 – ident: e_1_3_5_49_2 doi: 10.1093/molbev/msab120 – ident: e_1_3_5_2_2 doi: 10.1128/CMR.16.2.242-264.2003 – ident: e_1_3_5_42_2 doi: 10.1016/j.jviromet.2023.114812 – ident: e_1_3_5_25_2 doi: 10.1038/s41598-018-24767-4 – ident: e_1_3_5_27_2 doi: 10.1016/0042-6822(89)90508-4 – ident: e_1_3_5_47_2 doi: 10.1093/nar/gky427 – volume: 90 start-page: 6642 year: 2016 end-page: 6656 ident: B21 article-title: HSP90 chaperoning in addition to phosphoprotein required for folding but not for supporting enzymatic activities of measles and nipah virus L polymerases publication-title: J Virol doi: 10.1128/JVI.00602-16 – volume: 7 year: 2012 ident: B23 article-title: Genome sequencing and phylogenetic analysis of 39 human parainfluenza virus type 1 strains isolated from 1997-2010 publication-title: PLoS One doi: 10.1371/journal.pone.0046048 – volume: 8 year: 2018 ident: B24 article-title: Clinical and molecular epidemiology of human parainfluenza viruses 1-4 in children from Viet Nam publication-title: Sci Rep doi: 10.1038/s41598-018-24767-4 – volume: 283 year: 2020 ident: B45 article-title: Applying next-generation sequencing to unravel the mutational landscape in viral quasispecies publication-title: Virus Res doi: 10.1016/j.virusres.2020.197963 – volume: 9 year: 2013 ident: B28 article-title: Structure of the parainfluenza virus 5 (PIV5) hemagglutinin-neuraminidase (HN) ectodomain publication-title: PLoS Pathog doi: 10.1371/journal.ppat.1003534 – volume: 7 year: 2016 ident: B7 article-title: Features of circulating parainfluenza virus required for growth in human airway publication-title: mBio doi: 10.1128/mBio.00235-16 – volume: 117 start-page: 4931 year: 2020 end-page: 4941 ident: B19 article-title: Structure of a paramyxovirus polymerase complex reveals a unique methyltransferase-CTD conformation publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.1919837117 – volume: 12 year: 2022 ident: B34 article-title: SARS-CoV-2 quasi-species analysis from patients with persistent nasopharyngeal shedding publication-title: Sci Rep doi: 10.1038/s41598-022-22060-z – volume: 45 start-page: 2260 year: 2007 end-page: 2262 ident: B43 article-title: Increased detection of respiratory syncytial virus, influenza viruses, parainfluenza viruses, and adenoviruses with real-time PCR in samples from patients with respiratory symptoms publication-title: J Clin Microbiol doi: 10.1128/JCM.00848-07 – volume: 11 year: 2022 ident: B40 article-title: Ten nearly complete genome sequences of human orthorubulavirus 4 isolated from pediatric inpatients in Fukushima, Japan publication-title: Microbiol Resour Announc doi: 10.1128/mra.00411-22 – volume: 85 start-page: 12867 year: 2011 end-page: 12880 ident: B29 article-title: Spring-loaded model revisited: paramyxovirus fusion requires engagement of a receptor binding protein beyond initial triggering of the fusion protein publication-title: J Virol doi: 10.1128/JVI.05873-11 – volume: 171 start-page: 38 year: 1989 end-page: 48 ident: B26 article-title: Extensive antigenic diversity among human parainfluenza type 2 virus isolates and immunological relationships among paramyxoviruses revealed by monoclonal antibodies publication-title: Virology doi: 10.1016/0042-6822(89)90508-4 – volume: 4 start-page: 613 year: 2012 end-page: 636 ident: B17 article-title: Paramyxovirus fusion and entry: multiple paths to a common end publication-title: Viruses doi: 10.3390/v4040613 – volume: 102 start-page: 19 year: 2018 end-page: 26 ident: B4 article-title: In vitro sensitivity of human parainfluenza 3 clinical isolates to ribavirin, favipiravir and zanamivir publication-title: J Clin Virol doi: 10.1016/j.jcv.2018.02.009 – volume: 73 start-page: 875 year: 1992 end-page: 884 ident: B25 article-title: Antigenic diversity of human parainfluenza virus type 1 isolates and their immunological relationship with Sendai virus revealed by using monoclonal antibodies publication-title: J Gen Virol doi: 10.1099/0022-1317-73-4-875 – volume: 46 start-page: W296 year: 2018 end-page: W303 ident: B46 article-title: SWISS-MODEL: homology modelling of protein structures and complexes publication-title: Nucleic Acids Res doi: 10.1093/nar/gky427 – volume: 5 year: 2020 ident: B20 article-title: The role of furin cleavage site in SARS-CoV-2 spike protein-mediated membrane fusion in the presence or absence of trypsin publication-title: Signal Transduct Target Ther doi: 10.1038/s41392-020-0184-0 – volume: 4 year: 2013 ident: B9 article-title: Interaction between the hemagglutinin-neuraminidase and fusion glycoproteins of human parainfluenza virus type III regulates viral growth in vivo publication-title: mBio doi: 10.1128/mBio.00803-13 – volume: 87 start-page: 11930 year: 2013 end-page: 11935 ident: B18 article-title: TMPRSS2 is an activating protease for respiratory parainfluenza viruses publication-title: J Virol doi: 10.1128/JVI.01490-13 – volume: 61 start-page: 196 year: 2008 end-page: 201 ident: B3 article-title: Analysis of monthly isolation of respiratory viruses from children by cell culture using a microplate method: a two-year study from 2004 to 2005 in Yamagata, Japan publication-title: Jpn J Infect Dis doi: 10.7883/yoken.JJID.2008.196 – volume: 38 start-page: 3022 year: 2021 end-page: 3027 ident: B48 article-title: MEGA11: molecular evolutionary genetics analysis version 11 publication-title: Mol Biol Evol doi: 10.1093/molbev/msab120 – volume: 86 start-page: 12838 year: 2012 end-page: 12848 ident: B31 article-title: Regulation of paramyxovirus fusion activation: the hemagglutinin-neuraminidase protein stabilizes the fusion protein in a pretriggered state publication-title: J Virol doi: 10.1128/JVI.01965-12 – volume: 20 start-page: 1160 year: 2019 end-page: 1166 ident: B47 article-title: MAFFT online service: multiple sequence alignment, interactive sequence choice and visualization publication-title: Brief Bioinform doi: 10.1093/bib/bbx108 – volume: 16 start-page: 242 year: 2003 end-page: 264 ident: B1 article-title: Parainfluenza viruses publication-title: Clin Microbiol Rev doi: 10.1128/CMR.16.2.242-264.2003 – volume: 79 start-page: 2383 year: 2005 end-page: 2392 ident: B27 article-title: Influence of the human parainfluenza virus 3 attachment protein's neuraminidase activity on its capacity to activate the fusion protein publication-title: J Virol doi: 10.1128/JVI.79.4.2383-2392.2005 – volume: 12 year: 2024 ident: B11 article-title: Evidence of the simultaneous replications of active viruses in specimens positive for multiple respiratory viruses publication-title: Microbiol Spectr doi: 10.1128/spectrum.01920-23 – volume: 10 year: 2021 ident: B14 article-title: Human airway cells prevent SARS-CoV-2 multibasic cleavage site cell culture adaptation publication-title: Elife doi: 10.7554/eLife.66815 – volume: 89 start-page: 1330 year: 2017 end-page: 1338 ident: B35 article-title: Interpatient mutational spectrum of human coronavirus-OC43 revealed by illumina sequencing publication-title: J Med Virol doi: 10.1002/jmv.24780 – volume: 322 start-page: 114812 year: 2023 ident: B41 article-title: Development of a duplex real-time RT-PCR assay for the detection and identification of two subgroups of human metapneumovirus in a single tube publication-title: J Virol Methods doi: 10.1016/j.jviromet.2023.114812 – volume: 60 start-page: 801 year: 2016 end-page: 805 ident: B2 article-title: Efficient isolation of human parainfluenza viruses 1 and 3 using MNT-1, a human malignant melanoma cell line system that exhibits an apparent cytopathic effect publication-title: Microbiol Immunol doi: 10.1111/1348-0421.12446 – volume: 63 start-page: 570 year: 2014 end-page: 577 ident: B36 article-title: Molecular evolution of the haemagglutinin-neuraminidase gene in human parainfluenza virus type 3 isolates from children with acute respiratory illness in Yamagata prefecture, Japan publication-title: J Med Microbiol doi: 10.1099/jmm.0.068189-0 – volume: 517 start-page: 9 year: 2018 end-page: 15 ident: B38 article-title: Wild-type human coronaviruses prefer cell-surface TMPRSS2 to endosomal cathepsins for cell entry publication-title: Virology doi: 10.1016/j.virol.2017.11.012 – volume: 3 year: 2012 ident: B6 article-title: Adaptation of human parainfluenza virus to airway epithelium reveals fusion properties required for growth in host tissue publication-title: mBio doi: 10.1128/mBio.00137-12 – volume: 88 start-page: 13495 year: 2014 end-page: 13502 ident: B8 article-title: Circulating clinical strains of human parainfluenza virus reveal viral entry requirements for in vivo infection publication-title: J Virol doi: 10.1128/JVI.01965-14 – volume: 8 year: 2013 ident: B12 article-title: Comparison of mutation patterns in full-genome A/H3N2 influenza sequences obtained directly from clinical samples and the same samples after a single MDCK passage publication-title: PLoS ONE doi: 10.1371/journal.pone.0079252 – volume: 83 start-page: 6900 year: 2009 end-page: 6908 ident: B30 article-title: Human parainfluenza virus infection of the airway epithelium: viral hemagglutinin-neuraminidase regulates fusion protein activation and modulates infectivity publication-title: J Virol doi: 10.1128/JVI.00475-09 – volume: 10 year: 2019 ident: B10 article-title: Authentic modeling of human respiratory virus infection in human pluripotent stem cell-derived lung organoids publication-title: mBio doi: 10.1128/mBio.00723-19 – volume: 20 year: 2019 ident: B44 article-title: VAPiD: a lightweight cross-platform viral annotation pipeline and identification tool to facilitate virus genome submissions to NCBI GenBank publication-title: BMC Bioinformatics doi: 10.1186/s12859-019-2606-y – volume: 9 year: 2023 ident: B33 article-title: Collective fusion activity determines neurotropism of an en bloc transmitted enveloped virus publication-title: Sci Adv doi: 10.1126/sciadv.adf3731 – volume: 12 year: 2021 ident: B15 article-title: SARS-CoV-2 bearing a mutation at the S1/S2 cleavage site exhibits attenuated virulence and confers protective immunity publication-title: mBio doi: 10.1128/mBio.01415-21 – volume: 67 start-page: 469 year: 2014 end-page: 475 ident: B42 article-title: Associations between co-detected respiratory viruses in children with acute respiratory infections publication-title: Jpn J Infect Dis doi: 10.7883/yoken.67.469 – volume: 101 start-page: 925 year: 2020 end-page: 940 ident: B13 article-title: SARS-coronavirus-2 replication in Vero E6 cells: replication kinetics, rapid adaptation and cytopathology publication-title: J Gen Virol doi: 10.1099/jgv.0.001453 – volume: 46 start-page: 2189 year: 2008 end-page: 2194 ident: B16 article-title: MDCK-SIAT1 cells show improved isolation rates for recent human influenza viruses compared to conventional MDCK cells publication-title: J Clin Microbiol doi: 10.1128/JCM.00398-08 – volume: 131 year: 2021 ident: B32 article-title: Human parainfluenza virus evolution during lung infection of immunocompromised individuals promotes viral persistence publication-title: J Clin Invest doi: 10.1172/JCI150506 – volume: 82 start-page: 8942 year: 2008 end-page: 8946 ident: B37 article-title: Efficient multiplication of human metapneumovirus in Vero cells expressing the transmembrane serine protease TMPRSS2 publication-title: J Virol doi: 10.1128/JVI.00676-08 – volume: 11 year: 2022 ident: B39 article-title: Practical validation of United States centers for disease control and prevention assays for the detection of human respiratory syncytial virus in pediatric inpatients in Japan publication-title: Pathogens doi: 10.3390/pathogens11070754 – volume: 9 year: 2018 ident: B5 article-title: Viral entry properties required for fitness in humans are lost through rapid genomic change during viral isolation publication-title: mBio doi: 10.1128/mBio.00898-18 – volume: 362 start-page: 109 year: 2007 end-page: 119 ident: B22 article-title: Antiviral activity and RNA polymerase degradation following Hsp90 inhibition in a range of negative strand viruses publication-title: Virology doi: 10.1016/j.virol.2006.12.026 |
| SSID | ssj0001105252 |
| Score | 2.3196955 |
| Snippet | Adaptation of viruses to cultured cells can increase the risk of misinterpretation in virological characterization of clinical isolates. In human parainfluenza... Human parainfluenza virus (HPIV) causes respiratory infections, which are exacerbated in children and older people. Correct evaluation of viral characteristics... ABSTRACT Human parainfluenza virus (HPIV) causes respiratory infections, which are exacerbated in children and older people. Correct evaluation of viral... |
| SourceID | doaj pubmedcentral proquest asm2 pubmed crossref nii |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | e0116424 |
| SubjectTerms | air-liquid interface culture cell culture adaptation hemagglutinin neuraminidase protein human parainfluenza virus Microbiology QR1-502 quasispecies Research Article Virology |
| SummonAdditionalLinks | – databaseName: Amer. Society for Microbiology Open Access (Activated by CARLI) dbid: AAUOK link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3di9QwEA_nHoIv4rernkQQBKF3zUfT5HE9PA4FfXHh3krSJljY7Z7tVdD_xv_UmfRDV47Dl7I0mTZkJs1vdia_IeR1qh3LypIl1lc8kd4r-BVYonyGBy-VViEmyH5S52v54SK7OCBqOgszzmB3bLttDOTPK5vrk3j4sO23xxg9kAmXt8hhxo1MF-RwtVp__vjn3xWG9dn4GMa8Vha-wfAOvrcfRdp-2GWaur4Ocf6bOPnXTnR2j9wdISRdDTq_Tw5884DcHopK_nhIfp3OpQXpLtBtPwTbO1o3NFbko0j3XQ_FSX5a-r1u-853dDiwCI0d5pph78uBiWKUcu2uwcTozQkMqkSASf0lnujYwD1q6zbZ1N_6uqLIQNEGW3o60HrAs21TUQwRUAS13SOyPnv_5fQ8GQsxJBbw0FXihDVpMFXOnDLGGs2dN5l0TChpSpXagERouRbMl7wEh1HyoHxwMoSADop4TBbNrvFPCU0D2ERmvctKLgPIKJ56y5VVErCVN0vyBrVSTHZQRCeF62LSXxH1V3C5JOmkuKIc-cyxrMbmJpG3s8g4hTd1fofWMHdEHu54A6yyGJd1oZVQzoDPaiRsOTZokVaVBVjnBHIzwkOOwJZgfHhlOhdKg8-oADoAUs9TaH81WVkB6xo1YRu_67tCgK8JcBCMe0meDFY3D0UYpGiSekn0nj3ujXW_pam_Ru5wxkQOsEw9--95fk7ucJCIeXXiBVlAoz8CIHblXo6r7jdMsjMq priority: 102 providerName: American Society for Microbiology |
| Title | Comparison of mutations in human parainfluenza viruses during passage in primary human bronchial/tracheal epithelial air-liquid interface cultures and cell lines |
| URI | https://cir.nii.ac.jp/crid/1873680966341080704 https://www.ncbi.nlm.nih.gov/pubmed/39078148 https://journals.asm.org/doi/10.1128/spectrum.01164-24 https://www.proquest.com/docview/3086066940 https://pubmed.ncbi.nlm.nih.gov/PMC11370246 https://doaj.org/article/8636b989994146af830dda065b302274 |
| Volume | 12 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3di9QwEA-yIvgiflv1jgiCINRtPpomj-vhcSjoiwv3VpI2wcJu9669Ct5_c_-pM2l32RU5X3wpS5OU2cyk85tm8htC3mbasbyqWGp9zVPpvYJfgaXK53jwUmkVYoLsV3W2lJ_P8_O9Ul-YEzbSA48TN9dKKGcgKjASFrUNWmR1bcFxOoHsd5EJFHzeXjAVv64wrM_Gp21MeAfP48HFblh_wJ0HmeIJ95nt1_zAH0XafvAybdP8DXH-mTi554lOH5IHE4Ski1H0R-SObx-Te2NRyV9PyM3JrrQg3QS6HsbN9p42LY0V-SjSfTdjcZJrS3823dD7no4HFqGxx1wz7H0xMlFMo1y3aTExejUHoSoEmNRf4ImOFdyjtunSVXM5NDVFBoou2MrTkdYDnm3bmuIWAUVQ2z8ly9NP30_O0qkQQ2oBD12lTliTBVMXzCljrNHceZNLx4SSplKZDUiEVmjBfMUrCBglD8oHJ0MIGKCIZ2TWblr_gtAsgE3k1ru84jLAGMUzb7mySgK28iYh71Ar5bSS-jIGKVyXW_2VUX8llwnJtoorq4nPHMtqrG4b8n43ZJrC2zp_RGvYdUQe7ngDrLOcrLP8l3Um5AhsCeTDK9OFUBpiRgXQAZB6kUH7m62VlbCuURO29ZuhLwXEmgAHjcwS8ny0up0owiBFk9QJ0Qf2eCDrYUvb_Ijc4YyJAmCZevk__t0rcp_Dw2LKnXhNZjB__ggw2pU7JncXi-W3L8dxWf4GggY7kg |
| linkProvider | Directory of Open Access Journals |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3fb9MwELZgE4IXxG8KDIyEhISULbEd134sE1NhY7ys0t4sO7G1oDbdkmUS_Df8p9wlbqFomnipqtiXWrlz_V3u7jtC3qXKZXlRZIn1JUuE9xK-hSyRPsfCS6lk6BNkj-V0Jr6c5qcxqxJrYb5jX955u2vbRR_Hx42NL6JjP0K11xcgNt1iFyMIImHiNtnG2CFY9_ZkMvt2-OcNS4Y92lgMZV4rC__D8ENs40zqqfvhpKmr6jrU-W_y5F-n0cEDcj_CSDoZ9P6Q3PL1I3JnaCz54zH5tb9uL0iXgS66IeDe0qqmfVc-ipTf1dCg5KelV1XTtb6lQ9EiDLaYb4azzwc2iijlmmWNydHzPVhUgSCT-nOs6pjDNWqrJplXF11VUmShaIItPB2oPeDeti4phgkoAtv2CZkdfDrZnyaxGUNiARNdJo5bnQZdjjMntbZaMed1LlzGpdCFTG1AMrSx4pkvWAFOo2BB-uBECAGdFP6UbNXL2j8nNA1gF7n1Li-YCCAjWeotk1YKwFdej8h71IqJu6k1vaPClFnpz_T6M0yMSLpSnCkipzm21pjfJPJhLRIf4U2TP6I1rCciF3d_AUzTxK1tlOTSafBbtYBjxwbF07K0AO0cR35GuMkO2BKsDz8zNeZSgd8oAT4AWh-nMP52ZWUG9jZqwtZ-2bWGg78JkFCLdESeDVa3XgrXSNMk1IioDXvcWOvmSF2d9fzhWcbHAM3ki_9-zm_I3enJ1yNz9Pn48CW5x0C6z7Pjr8gWTPQ7AMwu3eu4A38DmZY3jQ |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3fb9MwELZgE4gXxG86GBgJCQkpW2I7jv1YBtVgaPBApb1ZdmJrkdq0NMsk-G_4T7lL3ELRNPESVbEvsXzn-Lve-TtCXqfKZXlZZon1FUuE9xJ-hSyRPseDl1LJ0CfInsrjqfh0lp_FrEo8CxNnsD2w7bwP5OPKXlYh1iNUh_0BxFU3P8AIgkiYuEl2MVgFNr47Hk-_nPz5hyXDGm0shjKvlIXvMLyHbe1JPXU_7DRNXV-FOv9NnvxrN5rcI3cjjKTjQe_3yQ3fPCC3hsKSPx6SX0eb8oJ0Eei8GwLuLa0b2lflo0j5XQ8FSn5aelmvuta3dDi0CI0t5pth7-XARhGl3GrRYHL07BAGVSLIpH6JpzpmcI_aepXM6u9dXVFkoVgFW3o6UHvAs21TUQwTUAS27SMynXz4dnScxGIMiQVMdJE4bnUadFVkTmpttWLO61y4jEuhS5nagGRoheKZL1kJTqNgQfrgRAgBnRT-mOw0i8Y_JTQNYBe59S4vmQggI1nqLZNWCsBXXo_IG9SKWduC6R0Vpsxaf6bXn2FiRNK14kwZOc2xtMbsOpG3G5E4hdd1fofWsOmIXNz9DbBME5e2UZJLp8Fv1QK2HRsUT6vKArRzHPkZ4SH7YEswPrxmquBSgd8oAT4AWi9SaH-1tjIDaxs1YRu_6FrDwd8ESKhFOiJPBqvbDIVrpGkSakTUlj1ujXW7panPe_7wLOMFQDO599_z_JLc_vp-Yj5_PD15Ru4wEO7T7PhzsgP9_D7gsgv3Ii7A30FONyk |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Comparison+of+mutations+in+human+parainfluenza+viruses+during+passage+in+primary+human+bronchial%2Ftracheal+epithelial+air-liquid+interface+cultures+and+cell+lines&rft.jtitle=Microbiology+spectrum&rft.au=Sugimoto%2C+Satoko&rft.au=Kawase%2C+Miyuki&rft.au=Suwa%2C+Reiko&rft.au=Kume%2C+Yohei&rft.date=2024-09-03&rft.issn=2165-0497&rft.eissn=2165-0497&rft.volume=12&rft.issue=9&rft.spage=e0116424&rft_id=info:doi/10.1128%2Fspectrum.01164-24&rft.externalDBID=NO_FULL_TEXT |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2165-0497&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2165-0497&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2165-0497&client=summon |